Odaily News NewLimit, founded by Coinbase CEO Brian Armstorng, has completed a $130 million Series B financing round led by Kleiner Perkins, with participation from Nat Friedman, Daniel Gross, Khosla Ventures, Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick Collison, and others. It is reported that the company mainly uses artificial intelligence models to develop anti-aging therapies and has discovered three prototype drugs that can reprogram liver cells. (TechCrunch)